September 28, 2026 |

Whitepapers / Reports

For Rare Disease Marketing, Precision Starts with the Care Pathway

For rare disease brands, traditional media planning can fall short when it relies on broad audience segments, conventional HCP lists, or channel-by-channel activation. The relevant patient population may be small and dispersed, while the route to diagnosis can span multiple specialties, referrals, tests, payers, caregivers, and advocacy communities.

For marketers, that complexity creates a familiar challenge. Read the full article, written by Joe Post, Client Lead, here.

Connect with CMI Media Group on LinkedIn.

For latest news and updates, follow us on Instagram, LinkedIn, and Facebook.

Questions? Thoughts? Ideas? Contact us.